Ameriprise’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $247M | Buy |
319,677
+27,758
| +10% | +$21.3M | 0.06% | 324 |
|
|
2025
Q4 | $226M | Buy |
291,919
+8,814
| +3% | +$5.99M | 0.05% | 342 |
|
|
2025
Q3 | $159M | Sell |
283,105
-4,594
| -2% | -$2.6M | 0.04% | 422 |
|
|
2025
Q2 | $152M | Sell |
287,699
-52,446
| -15% | -$29.3M | 0.04% | 427 |
|
|
2025
Q1 | $216M | Buy |
340,145
+13,594
| +4% | +$9.35M | 0.06% | 313 |
|
|
2024
Q4 | $232M | Sell |
326,551
-40,208
| -11% | -$33.7M | 0.06% | 302 |
|
|
2024
Q3 | $386M | Sell |
366,759
-8,119
| -2% | -$9.04M | 0.1% | 215 |
|
|
2024
Q2 | $395M | Buy |
374,878
+42,333
| +13% | +$41M | 0.11% | 202 |
|
|
2024
Q1 | $320M | Sell |
332,545
-3,306
| -1% | -$3.14M | 0.09% | 239 |
|
|
2023
Q4 | $295M | Sell |
335,851
-29,823
| -8% | -$24.6M | 0.09% | 239 |
|
|
2023
Q3 | $301M | Sell |
365,674
-10,854
| -3% | -$8.53M | 0.1% | 210 |
|
|
2023
Q2 | $271M | Buy |
376,528
+18,580
| +5% | +$14.3M | 0.08% | 244 |
|
|
2023
Q1 | $294M | Buy |
357,948
+22,584
| +7% | +$17M | 0.1% | 223 |
|
|
2022
Q4 | $242M | Buy |
335,364
+39,864
| +13% | +$29.4M | 0.08% | 249 |
|
|
2022
Q3 | $204M | Sell |
295,500
-12,936
| -4% | -$8.14M | 0.08% | 271 |
|
|
2022
Q2 | $182M | Sell |
308,436
-90,395
| -23% | -$58.8M | 0.06% | 311 |
|
|
2022
Q1 | $278M | Sell |
398,831
-8,165
| -2% | -$5.17M | 0.08% | 255 |
|
|
2021
Q4 | $257M | Buy |
406,996
+26,327
| +7% | +$16.2M | 0.07% | 290 |
|
|
2021
Q3 | $230M | Sell |
380,669
-30,628
| -7% | -$19M | 0.07% | 287 |
|
|
2021
Q2 | $230M | Buy |
411,297
+126,731
| +45% | +$64.2M | 0.07% | 292 |
|
|
2021
Q1 | $135M | Buy |
284,566
+11,724
| +4% | +$5.71M | 0.04% | 400 |
|
|
2020
Q4 | $132M | Sell |
272,842
-3,764
| -1% | -$2.03M | 0.05% | 401 |
|
|
2020
Q3 | $155M | Buy |
276,606
+4,209
| +2% | +$2.55M | 0.06% | 306 |
|
|
2020
Q2 | $170M | Sell |
272,397
-16,695
| -6% | -$9.48M | 0.07% | 266 |
|
|
2020
Q1 | $141M | Sell |
289,092
-27,220
| -9% | -$11.2M | 0.07% | 259 |
|
|
2019
Q4 | $119M | Buy |
316,312
+632
| +0.2% | +$213K | 0.05% | 350 |
|
|
2019
Q3 | $87.6M | Buy |
315,680
+26,733
| +9% | +$7.91M | 0.04% | 449 |
|
|
2019
Q2 | $90.4M | Buy |
288,947
+3,198
| +1% | +$1.06M | 0.04% | 454 |
|
|
2019
Q1 | $117M | Sell |
285,749
-12,556
| -4% | -$5.17M | 0.05% | 351 |
|
|
2018
Q4 | $111M | Buy |
298,305
+1,128
| +0.4% | +$413K | 0.06% | 341 |
|
|
2018
Q3 | $120M | Sell |
297,177
-18,346
| -6% | -$6.98M | 0.04% | 395 |
|
|
2018
Q2 | $109M | Buy |
315,523
+36,669
| +13% | +$11.5M | 0.05% | 387 |
|
|
2018
Q1 | $96M | Buy |
278,854
+30,853
| +12% | +$10.7M | 0.04% | 395 |
|
|
2017
Q4 | $93.2M | Buy |
248,001
+28,984
| +13% | +$11.7M | 0.04% | 394 |
|
|
2017
Q3 | $97.9M | Buy |
219,017
+1,809
| +0.8% | +$861K | 0.05% | 374 |
|
|
2017
Q2 | $107M | Sell |
217,208
-60,850
| -22% | -$26.6M | 0.05% | 335 |
|
|
2017
Q1 | $108M | Sell |
278,058
-74,762
| -21% | -$27.7M | 0.06% | 329 |
|
|
2016
Q4 | $130M | Buy |
352,820
+79,810
| +29% | +$30.3M | 0.07% | 285 |
|
|
2016
Q3 | $110M | Buy |
273,010
+196,415
| +256% | +$78.8M | 0.06% | 318 |
|
|
2016
Q2 | $26.7M | Buy |
76,595
+41,590
| +119% | +$16M | 0.02% | 756 |
|
|
2016
Q1 | $12.6M | Sell |
35,005
-57,581
| -62% | -$23.7M | 0.01% | 1244 |
|
|
2015
Q4 | $50.6M | Sell |
92,586
-84,515
| -48% | -$45.8M | 0.03% | 471 |
|
|
2015
Q3 | $82.4M | Buy |
177,101
+94,614
| +115% | +$50.8M | 0.05% | 332 |
|
|
2015
Q2 | $42.1M | Buy |
82,487
+1,420
| +2% | +$693K | 0.02% | 596 |
|
|
2015
Q1 | $36.6M | Buy |
81,067
+47,103
| +139% | +$20M | 0.02% | 656 |
|
|
2014
Q4 | $13.9M | Buy |
33,964
+1,735
| +5% | +$682K | 0.01% | 1224 |
|
|
2014
Q3 | $11.6M | Sell |
32,229
-1,291
| -4% | -$433K | 0.01% | 1340 |
|
|
2014
Q2 | $9.47M | Buy |
33,520
+584
| +2% | +$173K | 0.01% | 1583 |
|
|
2014
Q1 | $9.89M | Sell |
32,936
-39,530
| -55% | -$12.2M | 0.01% | 1531 |
|
|
2013
Q4 | $19.9M | Sell |
72,466
-111,360
| -61% | -$32M | 0.01% | 995 |
|
|
2013
Q3 | $57.5M | Buy |
183,826
+45,813
| +33% | +$12.1M | 0.04% | 488 |
|
|
2013
Q2 | $31M | Buy |
+138,013
| New | +$32.1M | 0.02% | 733 |
|
Other funds holding REGN
VCM
N
Ameriprise's REGN Position: Q1 2026 in Review
Ameriprise increased its Regeneron Pharmaceuticals (REGN) stake by 9.5% in Q1 2026, buying an estimated $21.3M and bringing the position to 319,677 shares worth $247M. The position accounts for 0.06% of the portfolio, ranked #324.
Ameriprise first reported a position in REGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $395M in Q2 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.
- Ameriprise held 319,677 shares of Regeneron Pharmaceuticals worth $247M as of Q1 2026.
- Ameriprise bought 27,758 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $21.3M.
- Regeneron Pharmaceuticals made up 0.06% of Ameriprise's portfolio in Q1 2026, its #324 holding.
- Ameriprise first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- Ameriprise's Regeneron Pharmaceuticals position peaked at $395M in Q2 2024.
- 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.